Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats

Neuropsychopharmacology

Volumn 37, Issue 5, 2012, Pages 1305-1320

  Sun, Jian Dong ^a   Liu, Yan ^a   Yuan, Yu He ^a   Li, Jing ^a   Chen, Nai Hong ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

antidepressant; chronic unpredictable stress; connexin 43; depression; gap junction; glucocorticoid receptor

Indexed keywords

CARBENOXOLONE; CONNEXIN 43; DULOXETINE; FLUOXETINE; MIFEPRISTONE; SUCROSE;

ANHEDONIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; ASTROCYTE; BEHAVIOR; BRAIN DYSFUNCTION; CELL FUNCTION; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DIFFUSION; DRUG INFUSION; GAP JUNCTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CARBENOXOLONE; CONNEXIN 43; DISEASE MODELS, ANIMAL; ELECTROSHOCK; EXPLORATORY BEHAVIOR; FLUOXETINE; FOOD DEPRIVATION; FOOD PREFERENCES; GAP JUNCTIONS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HORMONE ANTAGONISTS; INHIBITION (PSYCHOLOGY); ISOQUINOLINES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIFEPRISTONE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL; SUCROSE; SWEETENING AGENTS; SWIMMING; THIOPHENES;

EID: 84858336871     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.319     Document Type: Article

References (68)

1. Araque A, Parpura V, Sanzgiri RP, Haydon PG (1999). Tripartite synapses: Glia, the unacknowledged partner. Trends Neurosci 22: 208-215.
2. Ayensu WK, Pucilowski O, Mason GA, Overstreet DH, Rezvani AH, Janowsky DS (1995). Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol Behav 57: 165-169.
3. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL et al (2010). Glial pathology in an animal model of depression: Reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 15: 501-511.
4. Banasr M, Duman RS (2008). Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 64: 863-870.
5. Banasr M, Valentine GW, Li XY, Gourley SL, Taylor JR, Duman RS (2007). Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 62: 496-504.
6. Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (2001). Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol 21: 516-521.
7. Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C et al (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52: 386-392.
8. Bujalska I, Shimojo M, Howie A, Stewart PM (1997). Human 11 beta-hydroxysteroid dehydrogenase: Studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids 62: 77-82.
9. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP (2002). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12: 386-394.
10. Cotter D, Mackay D, Landau S, Kerwin R, Everall I (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58: 545-553.
11. Cruz NF, Ball KK, Dienel GA (2007). Functional imaging of focal brain activation in conscious rats: Impact of [(14)C]glucose metabolite spreading and release. J Neurosci Res 85: 3254-3266.
12. Czeh B, Simon M, Schmelting B, Hiemke C, Fuchs E (2006). Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31: 1616-1626.
13. Davidson JS, Baumgarten IM (1988). Glycyrrhetinic acid derivatives: A novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J Pharmacol Exp Ther 246: 1104-1107.
14. DeBattista C, Belanoff J, Glass S, Khan A, Horne RL, Blasey C et al (2006). Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry 60: 1343-1349.
15. Dermietzel R, Hertberg EL, Kessler JA, Spray DC (1991). Gap junctions between cultured astrocytes: Immunocytochemical, molecular, and electrophysiological analysis. J Neurosci 11: 1421-1432.
16. Evans WH, Leybaert L (2007). Mimetic peptides as blockers of connexin channel-facilitated intercellular communication. Cell Commun Adhes 14: 265-273.
17. Fatemi SH, Folsom TD, Reutiman TJ, Pandian T, Braun NN, Haug K (2008). Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats. Schizophr Res 104: 127-134.
18. Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF (2006). Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31: 628-636.
19. Frantseva MV, Kokarovtseva L, Perez Velazquez JL (2002). Ischemia-induced brain damage depends on specific gapjunctional coupling. J Cereb Blood Flow Metab 22: 453-462.
20. Gajda Z, Gyengesi E, Hermesz E, Ali KS, Szente M (2003). Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo. Epilepsia 44: 1596-1600.
21. Giaume C, Fromaget C, el A, Cordier J, Glowinski J, Gros D (1991). Gap junctions in cultured astrocytes: Single-channel currents and characterization of channel-forming protein. Neuron 6: 133-143.
22. Giaume C, Koulakoff A, Roux L, Holcman D, Rouach N (2010). Astroglial networks: A step further in neuroglial and gliovascular interactions. Nat Rev Neurosci 11: 87-99.
23. Giaume C, Theis M (2010). Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system. Brain Res Rev 63: 160-176.
24. Gosselin RD, Gibney S, O'Malley D, Dinan TG, Cryan JF (2009). Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 159: 915-925.
25. Harris AL (2007). Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol 94: 120-143.
26. Herman JP, Adams D, Prewitt C (1995). Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 61: 180-190.
27. Herrero-Gonzalez S, Valle-Casuso JC, Sanchez-Alvarez R, Giaume C, Medina JM, Tabernero A (2009). Connexin43 is involved in the effect of endothelin-1 on astrocyte proliferation and glucose uptake. Glia 57: 222-233.
28. Herve JC, Sarrouilhe D (2005). Connexin-made channels as pharmacological targets. Curr Pharm Des 11: 1941-1958.
29. Holsboer F, Barden N (1996). Antidepressants and hypothalamicpituitary- adrenocortical regulation. Endocr Rev 17: 187-205.
30. Hosseinzadeh H, Asl MN, Parvardeh S, Tagi Mansouri SM (2005). The effects of carbenoxolone on spatial learning in the Morris water maze task in rats. Med Sci Monit 11: BR88-BR94.
31. Jasinska M, Siucinska E, Glazewski S, Pyza E, Kossut M (2006). Characterization and plasticity of the double synapse spines in the barrel cortex of the mouse. Acta Neurobiol Exp (Wars) 66: 99-104.
32. Kimelberg HK (2007). Supportive or information-processing functions of the mature protoplasmic astrocyte in the mammalian CNS? A critical appraisal. Neuron Glia Biol 3: 181-189.
33. Kokarovtseva L, Jaciw-Zurakiwsky T, Mendizabal AR, Frantseva MV, Perez Velazquez JL (2009). Excitability and gap junctionmediated mechanisms in nucleus accumbens regulate selfstimulation reward in rats. Neuroscience 159: 1257-1263.
34. Kunzelmann P, Schroder W, Traub O, Steinhauser C, Dermietzel R, Willecke K (1999). Late onset and increasing expression of the gap junction protein connexin30 in adult murine brain and long-term cultured astrocytes. Glia 25: 111-119.
35. Lopez JF, Akil H, Watson SJ (1999). Neural circuits mediating stress. Biol Psychiatry 46: 1461-1471.
36. Madsen TM, Yeh DD, Valentine GW, Duman RS (2005). Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex. Neuropsychopharmacology 30: 27-34.
37. Miguel-Hidalgo J, Shoyama Y, Wanzo V (2009). Infusion of gliotoxins or a gap junction blocker in the prelimbic cortex increases alcohol preference in Wistar rats. J Psychopharmacol 23: 550-557.
38. Molteni R, Calabrese F, Cattaneo A, Mancini M, Gennarelli M, Racagni G et al (2009). Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 34: 1523-1532.
39. Nagy JI, Rash JE (2000). Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev 32: 29-44.
40. Nilsen KE, Kelso AR, Cock HR (2006). Antiepileptic effect of gapjunction blockers in a rat model of refractory focal cortical epilepsy. Epilepsia 47: 1169-1175.
41. Ongur D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295.
42. Oomen CA, Mayer JL, de Kloet ER, Joels M, Lucassen PJ (2007). Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. Eur J Neurosci 26: 3395-3401.
43. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.
44. Perea G, Navarrete M, Araque A (2009). Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci 32: 421-431.
45. Peters O, Schipke CG, Philipps A, Haas B, Pannasch U, Wang LP et al (2009). Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice. J Alzheimers Dis 18: 177-189.
46. Rajkowska G (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48: 766-777.
47. Rajkowska G, Miguel-Hidalgo JJ (2007). Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6: 219-233.
48. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY et al (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45: 1085-1098.
49. Ross FM, Gwyn P, Spanswick D, Davies SN (2000). Carbenoxolone depresses spontaneous epileptiform activity in the CA1 region of rat hippocampal slices. Neuroscience 100: 789-796.
50. Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C (2008). Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322: 1551-1555.
51. Samarasinghe RA, Di MR, Volonte D, Galbiati F, Lewis M, Romero G et al (2011). Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci USA 108: 16657-16662.
52. Samoilova M, Li J, Pelletier MR, Wentlandt K, Adamchik Y, Naus CC et al (2003). Epileptiform activity in hippocampal slice cultures exposed chronically to bicuculline: Increased gap junctional function and expression. J Neurochem 86: 687-699.
53. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R et al (2001). Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98: 1912-1917.
54. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
55. Scemes E, Giaume C (2006). Astrocyte calcium waves: What they are and what they do. Glia 54: 716-725.
56. Simpson GM, El SA, Loza N, Kingsbury SJ, Fayek M, Rady A et al (2005). An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. J Clin Psychiatry 66: 598-602.
57. Theis M, Jauch R, Zhuo L, Speidel D, Wallraff A, Doring B et al (2003). Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J Neurosci 23: 766-776.
58. Theis M, Sohl G, Eiberger J, Willecke K (2005). Emerging complexities in identity and function of glial connexins. Trends Neurosci 28: 188-195.
59. Wallraff A, Kohling R, Heinemann U, Theis M, Willecke K, Steinhauser C (2006). The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J Neurosci 26: 5438-5447.
60. Warner-Schmidt JL, Duman RS (2007). VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA 104: 4647-4652.
61. Willner P (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology (Berl) 134: 319-329.
62. Willner P (2005). Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90-110.
63. Willner P, Muscat R, Papp M (1992). Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci Biobehav Rev 16: 525-534.
64. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93: 358-364.
65. Wu LM, Han H, Wang QN, Hou HL, Tong H, Yan XB et al (2007). Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology 32: 2500-2510.
66. Xia X, Batra N, Shi Q, Bonewald LF, Sprague E, Jiang JX (2010). Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling.Mol Cell Biol 30: 206-219.
67. Xie M, Yi C, Luo X, Xu S, Yu Z, Tang Y et al (2011). Glial gap junctional communication involvement in hippocampal damage after middle cerebral artery occlusion. Ann Neurol 70: 121-132.
68. Zhang Y, Gu F, Chen J, Dong W (2010). Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res 1366: 141-148.